Valvoline Inc. (VVV) Q4 2026 Earnings Call November 19, 2026 9:00 AM EST
Company Participants
Elizabeth Clevinger – Investor Relations Executive
Lori Flees – CEO, President & Director
John Willis – Senior VP & CFO
Conference Call Participants
Steven Shemesh – RBC Capital Markets, Research Division
David Bellinger – Mizuho Securities USA LLC, Research Division
Mark Jordan – Goldman Sachs Group, Inc., Research Division
Maksim Rakhlenko – TD Cowen, Research Division
Bret Jordan – Jefferies LLC, Research Division
Michael Albanese – StoneX Financial, Inc., Research Division
Kevin Condon – Robert W. Baird & Co. Incorporated, Research Division
Scott Stember – ROTH Capital Partners, LLC, Research Division
David Lantz – Wells Fargo Securities, LLC, Research Division
John Babcock – Barclays Bank PLC, Research Division
Steven Zaccone – Citigroup Inc., Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to Valvoline’s Third (sic) [Fourth] Quarter 2026 Earnings Conference Call. [Operator Instructions]
I will now hand the conference over to Elizabeth Clevinger, Investor Relations. Elizabeth, please go ahead.
Elizabeth Clevinger
Investor Relations Executive
Thank you. Good morning, and welcome to Valvoline’s Fourth Quarter Fiscal 2026 Conference Call and Webcast. This morning, Valvoline released results for the fourth quarter and fiscal year ended September 30, 2026. This presentation should be viewed in conjunction with that earnings release, a copy of which is available on our Investor Relations website at investors.valvoline.com. Please note that these results are preliminary until we file our Form 10-K with the Securities and Exchange Commission.
On this morning’s call is Lori Flees, our President and CEO; and Kevin Willis, our CFO. As shown in the accompanying presentation, any of our remarks today that are not statements of historical facts are forward-looking statements. These forward-looking statements are based on current assumptions as of the date of this presentation and are subject to certain risks and uncertainties that may cause actual results to differ
Read the full article here






